Skip to content

NOR-SYS: The Norwegian Stroke in the Young Study

NOR-SYS: The Norwegian Stroke in the Young Study Young Ischemic Stroke and Family Risk Factors

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01597453
Acronym
NOR-SYS
Enrollment
1062
Registered
2012-05-14
Start date
2010-09-01
Completion date
2030-12-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Carotid Artery Disease, Death, Peripheral Artery Disease

Keywords

Young ischemic stroke, Families, Long-term follow-up

Brief summary

NOR-SYS is a clinical research program about young ischemic stroke patients from 15 to 60 years. Patients, partners and the couple´s adult children who are at least 18 years old, are all invited to ultrasound examinations due to a standardized protocol. Parents of patients and partners are invited to return their answers of standardized questionnaires about clinical ischemic events such as stroke, angina or myocardial infarction or peripheral artery disease. Study inclusion time of patients and their families is 5 years. A biobank is build from samples from patients, partners and adult children. Clinical follow-ups for patients and partners are planned after 5, 10 and 15 years. Clinical follow-ups for adult children are planned after 10 and 20 years. Hypotheses: What do patients know about their parents clinical ischemic events? How much established pathology in arteries do we find by a standardized ultrasound protocol at the time of ischemic stroke at a young age? Differences concerning risk factors and ultrasound findings between patients and partners? Differences between children from families with several ischemic events among parents and grandparents vs. children from families without ischemic events? Biochemical markers related to ultrasound findings and artery disease.

Detailed description

Equal examinations for patients, partners and adult children are: * Standardized questionnaires * Extracranial duplexsonography * Duplexsonography of the abdominal aorta * Duplexsonography of femoral arteries * Duplexsonography of epicardial, intrabdominal and subcutaneous fat * Peripheral ultrasound, Ankle-arm index * ECG * Blood pressure measurement * BMI and Waist-hip ratio * Blood samples

Interventions

BEHAVIORALLifestyle counseling

Ultrasound examinations of carotid arteries, aorta abdominalis, femoral arteries and lifestyle counseling

Sponsors

Haukeland University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Inclusion was completed in 2015, and the 5-year follow-up phase was completed in july 2021. The planned 10-year follow-up has not been possible due to the covid pandemia. A final 15 year follow-up was originally planned, and would start in 2025.

Eligibility

Sex/Gender
ALL
Age
15 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Documented ischemic stroke at age from 15 up to 60 years

Exclusion criteria

* Stroke as end-of-life event among patients with cancer or other life-threatening disease * Stroke caused by trauma

Design outcomes

Primary

MeasureTime frameDescription
All cause mortality15 years for patients and partners and 20 years for offspringOutcome measure is assessed every five years.

Secondary

MeasureTime frameDescription
Arterial events (recurrent stroke or transitory ischemic attack, myocardial infarction or angina, peripheral artery disease15 years for patients and partners and 20 years for offspringOutcome measure is assessed every five years.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026